The big winners of the tech wreck are biopharma stocks
Open the sourceReported by MarketWatch, marketwatch.com, 30 October 2026, by Jaimy Lee
50Impact 50 of 100, routine
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at marketwatch.com.
Named in this story
Gilead Sciences, Eli Lilly (LLY), Johnson & Johnson (JNJ)
A linked name opens that asset's sentiment page.